These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1668865

  • 1. [Development of a rotavirus vaccine. Field trials in Venezuela].
    Pérez Schael I, Rojas Mazzei AM, Flores J.
    Acta Cient Venez; 1991; 42(6):296-312. PubMed ID: 1668865
    [Abstract] [Full Text] [Related]

  • 2. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y, Kapikian AZ.
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela.
    Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM, González R, Cunto W, Hoshino Y, Kapikian AZ.
    N Engl J Med; 1997 Oct 23; 337(17):1181-7. PubMed ID: 9337376
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T, Rautanen T, Varis T, Beards GM, Kapikian AZ.
    Am J Dis Child; 1990 Mar 23; 144(3):285-9. PubMed ID: 2154925
    [Abstract] [Full Text] [Related]

  • 6. The present status of rotavirus vaccine development.
    Bishop R.
    Southeast Asian J Trop Med Public Health; 1988 Sep 23; 19(3):429-35. PubMed ID: 2851184
    [Abstract] [Full Text] [Related]

  • 7. Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.
    Kapikian AZ, Flores J, Hoshino Y, Midthun K, Gorziglia M, Green KY, Chanock RM, Potash L, Sears SD, Clements ML.
    Rev Infect Dis; 1989 Sep 23; 11 Suppl 3():S539-46. PubMed ID: 2548276
    [Abstract] [Full Text] [Related]

  • 8. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T, Karvonen AV, Majuri J, Zeng SQ, Pang XL, Kohberger R, Forrest BD, Hoshino Y, Chanock RM, Kapikian AZ.
    J Infect Dis; 2006 Aug 01; 194(3):370-6. PubMed ID: 16826486
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical and immunological studies of rotavirus vaccines.
    Vesikari T.
    Southeast Asian J Trop Med Public Health; 1988 Sep 01; 19(3):437-47. PubMed ID: 2851185
    [Abstract] [Full Text] [Related]

  • 11. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis.
    Heaton PM, Goveia MG, Miller JM, Offit P, Clark HF.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S17-21. PubMed ID: 16088800
    [Abstract] [Full Text] [Related]

  • 12. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T, Clark HF, Offit PA, Dallas MJ, DiStefano DJ, Goveia MG, Ward RL, Schödel F, Karvonen A, Drummond JE, DiNubile MJ, Heaton PM.
    Vaccine; 2006 May 29; 24(22):4821-9. PubMed ID: 16621194
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Frequency of serotype G rotavirus isolated from children with diarrhea in Mérida, Yucatán, Mexico].
    González-Losa MR, Puerto-Solís M, Polanco-Marín GG, Peniche-Rodríguez R, Puerto FI.
    Rev Invest Clin; 1994 May 29; 46(3):215-9. PubMed ID: 7973145
    [Abstract] [Full Text] [Related]

  • 15. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 29; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 16. Rotavirus vaccines: new drug. Rotavirus infection: one case of severe diarrhoea prevented per 100 vaccinated infants.
    Prescrire Int; 2007 Feb 29; 16(87):3-6. PubMed ID: 17323513
    [Abstract] [Full Text] [Related]

  • 17. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF, Offit PA, Plotkin SA, Heaton PM.
    Pediatr Infect Dis J; 2006 Jul 29; 25(7):577-83. PubMed ID: 16804425
    [Abstract] [Full Text] [Related]

  • 18. Rotavirus.
    Parashar UD, Bresee JS, Gentsch JR, Glass RI.
    Emerg Infect Dis; 1998 Jul 29; 4(4):561-70. PubMed ID: 9866732
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru.
    Lanata CF, Black RE, Flores J, Lazo F, Butron B, Linares A, Huapaya A, Ventura G, Gil A, Kapikian AZ.
    Vaccine; 1996 Feb 29; 14(3):237-43. PubMed ID: 8920706
    [Abstract] [Full Text] [Related]

  • 20. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF, Bernstein DI, Dennehy PH, Offit P, Pichichero M, Treanor J, Ward RL, Krah DL, Shaw A, Dallas MJ, Laura D, Eiden JJ, Ivanoff N, Kaplan KM, Heaton P.
    J Pediatr; 2004 Feb 29; 144(2):184-90. PubMed ID: 14760258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.